HXASP-028

N/A

Report date: 2025/01/06 17:00:34

Base Information

Drug NameHXASP-028
Drug Alias NameHXASP028HXASP-028
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMucocutaneous Lymph Node Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGuangxi Shanhe Baisheng Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsMucocutaneous Lymph Node Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A